Yes that is the hope, but I really can't say. The abstract was submitted some time ago (it needs to be peer reviewed by the ASH conference committee) and it is entirely possible that Dan's work was not finished before the abstract went in. If it is complete before December then we may see something in the presentation. We will just have to wait.
Ann: Impressive Bisantrene Phase 2 AML Clinical Results, page-73
-
- There are more pages in this discussion • 159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
